期刊文献+

内皮素系统在前列腺癌中的研究进展 被引量:3

Endothelin axis in prostate cancer
下载PDF
导出
摘要 内皮素(endothelin,ET)、ET受体(endothelin receptor,ETR)及与之相关的信号转导途径统称为内皮素系统,该系统参与了促有丝分裂、抑制细胞凋亡、促进新生血管形成、骨骼重塑、肿瘤侵袭、肿瘤免疫调节、上皮-间质细胞间转换、肿瘤局部侵犯与远处转移等前列腺癌病程中的各个阶段,在前列腺癌的发生、发展及转移中起着重要作用。此外,目前已有一些针对内皮素系统的前列腺癌靶向治疗手段或与其他前列腺癌治疗手段联合应用的研究,并取得良好效果。文中对内皮素系统在前列腺癌中的相关研究及临床应用的进展进行综述,为针对内皮素-1的前列腺癌靶向治疗和联合其它分子靶向治疗提供理论依据。 The endothelin axis,comprising endothelins,endothelin receptors and the endothelin signal transduction pathway,plays an important role in the pathogenesis,development and metastasis of prostate cancer by regulating mitogenesis,cell survival,angiogenesis,bone remodeling,stimulation of the nociceptor receptor,tumor-infiltrating immune cells,epithelial-mesenchymal transition,and tumor invasion and metastatic dissemination.This review highlights the key signaling pathways activated by the endothelin-1 axis in cancer,for an insight into the full spectrum activated by endothelin-1 is critical for the optimal design of targeted therapies.Preliminary experimental and clinical data demonstrate that interfering with endothelin receptors by using endothlin-1 receptor antagonists alone and in combination with cytotoxic drugs or molecular inhibitors could represent a new mechanism-based antitumor strategy.
出处 《医学研究生学报》 CAS 2011年第3期327-332,共6页 Journal of Medical Postgraduates
关键词 内皮素系统 前列腺癌 内皮素受体拮抗剂 Endothelin axis Prostate cancer Endothelin receptor antagonist
  • 相关文献

参考文献30

  • 1Yanagisawa M,Kurihara H,Kimura S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J].Nature,1988,332(6163):411-415.
  • 2Bagnato A,Rosano L.The endothelin axis in cancer[J].Int J Biochem Cell Biol,2008,40(8):1443-1451.
  • 3Fagan KA,Mcmutry LF,Rodman DM.Role of endothelin-1 in lung disease[J].Respir Res,2001,21(2):90-101.
  • 4Masaki T.The endothelin family:An overview[J].J Cardiovasc Pharmacolo.2000,35 (4 Suppl 2):S3-S5.
  • 5Rozengurt E.Mitogenic signaling pathways induced by G protein-coupled receptors[J].J Cell Physiol,2007,213(3):589-602.
  • 6Nelson JB,Bagnato A,Battistini B,et al.The endothelin axis:Emerging role in cancer[J].Nature Review Cancer,2003,3(2):110-116.
  • 7Kopetz ES,Nelson JB,Carducci M.Endothelin-1as a target for therapeutic intervention in prostate cancer[J].Invest New Drugs,2002,20(2):173-182.
  • 8Rosan′o L,Di Castro V,Spinella F,et al.Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity[J].Cancer Res,2007,67(13):6351-6359.
  • 9薄隽杰,黄旭元,孙杰,戴胜国,王益鑫.内皮素受体在雄激素非依赖性前列腺癌中的作用[J].中华外科杂志,2004,42(14):870-873. 被引量:7
  • 10Nelson JB,Udan MS,Guruli G,et al.Endothelin-1 inhibits apoptosis in prostate cancer[J].Neoplasia,2005,7(7):631-637.

二级参考文献59

  • 1刘浩,刘志勇.内皮素系统与肺动脉高压关系的研究进展[J].医学研究生学报,2006,19(4):373-376. 被引量:4
  • 2白安胜,曾浩,李响,魏强,李虹,杨宇如.血管内皮生长因子受体激酶插入嵌合受体在前列腺癌及良性前列腺增生组织中的表达[J].中华男科学杂志,2007,13(4):324-326. 被引量:3
  • 3Salani D, Taraboletti G, Rosano L, et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo[ J]. Am J Pathol, 2000, 157 (5) : 1703-1711.
  • 4Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor( vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract[J]. Cancer Res, 1993, 53(19) :4727-4735.
  • 5Yoshiji H, Gomez DE, Shibuya M, et al. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer[ J]. Cancer Res, 1996, 56 (9): 2013-2016.
  • 6Abdou AG, Aiad H, Asaad N,et al. Immunohistochemical evaluation of vascular endothelial growth factor (VEGF) in colorectal carcinoma [J]. J Egypt Natl Canc Inst, 2006, 18(4) :311-322.
  • 7Clauss M. Molecular biology of the VEGF and the VEGF receptor family[J]. Semin Thromb Hemost, 2000, 26(5) :561-569.
  • 8Kraft A, Weindel K, Ochs A, et al. V ascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease[J].Cancer. 1999, 85(1) : 178-187.
  • 9Weidner N. Intratumor microvessel density as a prognostic factor in cancer[ J]. Am J Pathol, 1995, 147( 1 ) :9-19.
  • 10Lee TK, Poon RT,Yuen AP, et al. Rac activation is associated with hcpatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression [ J ]. Clin Cancer Res, 2006, 12(17) :5082-5089.

共引文献21

同被引文献53

  • 1杨春明,刘海波,孙志熙,孔垂泽.凋亡抑制蛋白Livin在肾癌组织中的表达及临床意义[J].中国医科大学学报,2009,38(4):289-291. 被引量:6
  • 2范博,张开立,张亮,郭恩忠.DNA甲基化在肾癌诊治的应用[J].医学研究生学报,2011,24(8):870-873. 被引量:5
  • 3杨进益,叶林,刘天卿,周杰,姜洪波,侯旭,邓昕.BPH组织无症状性炎症的模式及临床意义[J].临床泌尿外科杂志,2005,20(6):334-336. 被引量:3
  • 4叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 5AHMEDIN J,REBECCA S,JIAQUAN X,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60:277-300.
  • 6PLATICA M,IVAN E,IONESCU A,et al.Transformation of NIH3T3 cells by enhanced PAR expression[J].Biochem Biophys Res Commun,2004,314(3):891-896.
  • 7BAGHERIi-YARMAND R,NANOS-WEBB A,BIERNACKA A,et al.Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C[J].Cancer Res,2010,70(12):5085-5095.
  • 8WANG Z,TROPE C G,FLORENES V A,et al.Overexpression of CDC25B,CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes[J].BMC Cancer,2010,10:233.
  • 9GARCIA-MORALES P,CARRASCO-GARCIA E,et al.Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G(2)/M arrest in glioblastoma cell lines[J].Oncogene,2007,26(51):7185-7193.
  • 10ATTAR R M,TAKIMOTO C H,GOTTARDIS M M.Castration-resistant prostate cancer:locking up the molecular escape routes[J].Clin Cancer Res,2009,15(10):3251-3255.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部